Loss of Keratin K2 Expression Causes Aberrant Aggregation of K10, Hyperkeratosis, and Inflammation

Total Page:16

File Type:pdf, Size:1020Kb

Loss of Keratin K2 Expression Causes Aberrant Aggregation of K10, Hyperkeratosis, and Inflammation ORIGINAL ARTICLE Loss of Keratin K2 Expression Causes Aberrant Aggregation of K10, Hyperkeratosis, and Inflammation Heinz Fischer1, Lutz Langbein2, Julia Reichelt3, Silke Praetzel-Wunder2, Maria Buchberger1, Minoo Ghannadan1, Erwin Tschachler1 and Leopold Eckhart1 Keratin K2 is one of the most abundant structural proteins of the epidermis; however, its biological significance has remained elusive. Here we show that suprabasal type II keratins, K1 and K2, are expressed in a mutually exclusive manner at different body sites of the mouse, with K2 being confined to the ear, sole, and tail skin. Deletion of K2 caused acanthosis and hyperkeratosis of the ear and the tail epidermis, corneocyte fragility, increased transepidermal water loss, and local inflammation in the ear skin. The loss of K2 was partially compensated by upregulation of K1 expression. However, a significant portion of K2-deficient suprabasal keratinocytes lacked a regular cytoskeleton and developed massive aggregates of the type I keratin, K10. Aggregate formation, but not hyperkeratosis, was suppressed by the deletion of both K2 and K10, whereas deletion of K10 alone caused clumping of K2 in ear skin. Taken together, this study demonstrates that K2 is a necessary and sufficient binding partner of K10 at distinct body sites of the mouse and that unbalanced expression of these keratins results in aggregate formation. Journal of Investigative Dermatology (2014) 134, 2579–2588; doi:10.1038/jid.2014.197; published online 29 May 2014 INTRODUCTION keratins lead to epidermal fragility (Omary et al., 2004). The Keratins are the main cytoskeletal proteins of epithelial cells deletion of K10 causes epidermal thickening and an including epidermal keratinocytes (Morley and Lane, 1994; enlargement of sebaceous glands (Reichelt and Magin, 2002; Candi et al., 2005; Moll et al., 2008). Distinct pairs of type I Reichelt et al., 2004). This mild phenotype was attributed to and type II keratins heterodimerize to form keratin interme- compensatory upregulation of the basal epidermal keratin K14 diate filaments that increase the mechanical resilience of (Reichelt et al., 2001). By contrast, the deletion of K1 results in epithelial cells besides having additional nonstructural roles a defect in skin barrier formation, inflammation, and perinatal (Morley and Lane, 1994; Magin et al., 2007; Pan et al., 2013; lethality (Roth et al., 2012). Ramms et al., 2013; Seltmann et al., 2013). Different muta- The expression of the type II keratin K2 (formerly K2e; Moll tions in keratin genes cause distinct epidermolytic bullous et al., 2008) is restricted to the uppermost suprabasal layers of diseases and certain forms of ichthyoses (Uitto et al., 2007; the epidermis (Rentrop et al., 1987; Collin et al.,1992;Herzog Arin, 2009; McLean and Moore, 2011). et al., 1994) where it colocalizes with the type I keratin K10 Epidermal keratinocytes express keratins in a strictly differ- (Smith et al., 1999). In humans, K2 is expressed throughout the entiation stage–dependent manner. K5 and K14 are expressed interfollicular epidermis but strongly increased in palmo- in the basal layer, whereas K1, K2, and K10 are confined to plantar skin and in the epidermis on other mechanically the suprabasal layers (Fuchs, 1990; Collin et al., 1992; Morley stressed body sites (Rothnagel et al., 1994; Swensson et al. and Lane, 1994; for a review, see Moll et al.,2008).The 1998). This expression pattern has led to the suggestion that K2 primary role of suprabasal keratins is to enhance the provides additional mechanical resilience to the epidermis. mechanical strength of the epidermis, and mutations in these KRT2 mutations that lead to the substitution of amino acid residues critical for filament formation cause ichthyosis bullosa 1Department of Dermatology, Medical University of Vienna, Vienna, Austria; of Siemens (Kremer et al., 1994; McLean et al.,1994; 2Department of Genetics of Skin Carcinogenesis, German Cancer Research Rothnagel et al., 1994). In this disease cell lysis occurs in 3 Center, Heidelberg, Germany and Institute of Cellular Medicine and North the spinous and granular epidermal layers upon mild stress, East England Stem Cell Institute, Newcastle University, Newcastle upon Tyne, UK which manifests particularly on soles, palms, knees, and Correspondence: Leopold Eckhart, Department of Dermatology, Medical elbows. Clinically, these lesions are characterized by acan- University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. thosis, vacuolization of the granular layer, and hyperkeratosis. E-mail: [email protected] Skin inflammation has been observed in this condition Abbreviations: DTT, dithiothreitol; IL, interleukin; PAGE, polyacrylamide gel (Basarab et al., 1999). As ichthyosis bullosa of Siemens is eletrophoresis; SDS, sodium dodecyl sulfate; TEWL, transepidermal water loss; caused by mutated K2 proteins that act in a dominant-negative TNF-a, tumor necrosis factor alpha; TSLP, thymic stromal lymphopoietin manner, the symptoms of ichthyosis bullosa of Siemens Received 27 November 2013; revised 24 March 2014; accepted 2 April 2014; accepted article preview online 21 April 2014; published online 29 are not informative about the physiological function of May 2014 normal K2. & 2014 The Society for Investigative Dermatology www.jidonline.org 2579 HFischeret al. Role of Keratin Pair K2/K10 in Skin Barrier K2 K2 K1 K1 * * K2 + K1 K2 + K1 ##* Nail K2 + K1 ** Nail # # K2 + K1 Figure 1. Keratins K1 and K2 are differentially expressed in the epidermis of the mouse. (a–d) Immunofluorescence labeling of K1 (red) and K2 (green) in the skin of the ears (a), back (b), tail (c), and paw (d) of C57BL/6 wild-type mice. Nuclei were counterstained (blue) with Hoechst 33258. Asterisks mark infundibula of hair follicles. **The image of the paw is a compilation of pictures. (e, f) X-gal staining (blue) of beta-galactosidase expressed under the control of the Krt2 promoter in the tail (e) and toe (f)ofKrt2 þ / À mice. Arrows and arrowheads mark corresponding positions of the toe pad in d and f, whereas # symbols mark scales in c and e. Bars ¼ 40 mm(a, b), 100 mm(c), 200 mm(d). Here we investigate the role of K2 in epidermal homeostasis (Figure 1a–c). By contrast and surprisingly different from the by defining the expression patterns of suprabasal keratins in situation in human skin, K1 was absent from the interfolli- the mouse and by generating and characterizing K2-deficient cular epidermis of the mouse ear, whereas it was present in mice. We show that suprabasal epidermal keratinocytes of the infundibular regions (Figure 1a). In the back skin, which several murine body sites lack expression of K1 while expre- is densely covered by pelage hair follicles, K2 was absent, ssing K2 together with K10. The corresponding sites of K2 whereas K1 was expressed throughout the interfollicular knockout mice contain prominent K10 aggregates and epidermis (Figure 1b). In the tail skin, K1 and K2 were develop epidermal acanthosis and hyperkeratosis as well as confined to the interscale regions within which the infundi- skin inflammation. Together with our finding that K2 forms bulum regions of the sparse hair follicles contained K1 and aggregates in the absence of K10, our study establishes that the region more distant from the hair follicles contained K2 K2/K10 intermediate filaments are essential for normal epi- (Figure 1c). On the soles and footpads, K1 and K2 were also dermal morphology at specific body sites. expressed in an alternating pattern (Figure 1d, arrows). All skin sites that contained either K1 or K2 expressed K10 RESULTS (Supplementary Figure S1 online). Essentially the same Keratins K1 and K2 are differentially expressed in the suprabasal results were obtained by immunofluorescence analysis of ear and plantar epidermis the mouse strains C57BL/6, mixed 129/C57BL/6, mixed The expression patterns of K2 and K1 were determined by C57BL/6/Balb/c, and SKH-1. Together, these expression immunofluorescence labeling of the skin from various body patterns suggested that the suprabasal epidermis of the sites of wild-type (WT) mice (Figure 1). K2 was expressed in mouse has two mutually exclusive schemes of keratiniza- the suprabasal layers of the interfollicular epidermis of the tion, one involving the formation of intermediate filaments ear with the exception of the infundibulum of hair follicles made of K1/K10 heterodimers and the other involving the 2580 Journal of Investigative Dermatology (2014), Volume 134 HFischeret al. Role of Keratin Pair K2/K10 in Skin Barrier formation of intermediate filaments made of K2/K10 a Krt2 +/+ Krt2 –/– heterodimers. In an independent experimental approach, the activity of the murine Krt2 promoter was assessed in mice carrying a beta-galactosidase reporter gene inserted into one of the two Krt2 alleles (Supplementary Figure S2 online). Visualization of beta-galactosidase activity in situ revealed reporter gene expression in the ear skin (Supplementary Figure S3 online), in the interscale regions of tail skin (Figure 1e), and in those regions of the sole and toe pads that lacked eccrine sweat glands (Figure 1f, for overview and negative control see Supplementary Figure S3 online). No expression of the reporter gene was detected in the back skin of heterozygous mice (not shown) and in any tissue of WT mice that were used as negative controls (Supplementary Figure S3 online). Thus, +/+ –/– b Krt2 Krt2 the beta-galactosidase activity staining confirmed the expres- sion sites of K2 as detected by immunofluorescence analysis of tissue sections and revealed a highly patterned organization of Krt2 promoter activity on the tail as well as on the soles and toe pads. Further investigations were focused on the epidermis of the ears because of the uniform expression of K2 in the interfollicular epidermis at this body site. c d 3 Targeted deletion of K2 leads to hyperkeratosis, increased water 100 * * loss, and localized inflammation 80 ) To investigate the role of K2 in vivo, we generated mice in –1 h À / À 2 which both alleles of the Krt2 gene were disrupted (Krt2 ) 60 –2 (Supplementary Figure S2 online).
Recommended publications
  • Downregulation of Salivary Proteins, Protective Against Dental Caries, in Type 1 Diabetes
    proteomes Article Downregulation of Salivary Proteins, Protective against Dental Caries, in Type 1 Diabetes Eftychia Pappa 1,* , Konstantinos Vougas 2, Jerome Zoidakis 2 , William Papaioannou 3, Christos Rahiotis 1 and Heleni Vastardis 4 1 Department of Operative Dentistry, School of Dentistry, National and Kapodistrian University of Athens, 11527 Athens, Greece; [email protected] 2 Proteomics Laboratory, Biomedical Research Foundation Academy of Athens, 11527 Athens, Greece; [email protected] (K.V.); [email protected] (J.Z.) 3 Department of Preventive and Community Dentistry, School of Dentistry, National and Kapodistrian University of Athens, 11527 Athens, Greece; [email protected] 4 Department of Orthodontics, School of Dentistry, National and Kapodistrian University of Athens, 11527 Athens, Greece; [email protected] * Correspondence: effi[email protected] Abstract: Saliva, an essential oral secretion involved in protecting the oral cavity’s hard and soft tissues, is readily available and straightforward to collect. Recent studies have analyzed the sali- vary proteome in children and adolescents with extensive carious lesions to identify diagnostic and prognostic biomarkers. The current study aimed to investigate saliva’s diagnostic ability through proteomics to detect the potential differential expression of proteins specific for the occurrence of carious lesions. For this study, we performed bioinformatics and functional analysis of proteomic datasets, previously examined by our group, from samples of adolescents with regulated and unreg- ulated type 1 diabetes, as they compare with healthy controls. Among the differentially expressed Citation: Pappa, E.; Vougas, K.; proteins relevant to caries pathology, alpha-amylase 2B, beta-defensin 4A, BPI fold containing family Zoidakis, J.; Papaioannou, W.; Rahiotis, C.; Vastardis, H.
    [Show full text]
  • Why Pashmina Goat Produces Long Hair-Fiber and Barbari Doesn’T: a Differential Gene Expression Study
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 5 March 2021 doi:10.20944/preprints202103.0187.v1 Why Pashmina Goat Produces Long Hair-fiber and Barbari doesn’t: A Differential Gene Expression Study Rashid Saif 1, 2, Tania Mahmood2, Aniqa Ejaz2, Saeeda Zia3 1 Institute of Biotechnology, Gulab Devi Educational Complex, Lahore, Pakistan 2 Decode Genomics, Punjab University Employees Housing Scheme (II), Lahore, Pakistan 3 Department of Sciences and Humanities, National University of Computer and Emerging Sciences, Lahore, Pakistan Corresponding author: [email protected] Abstract: The Pashmina and Barbari are two famous goat breeds found in the wide areas of the Indo-Pak region. Pashmina is famous for its long hair-fiber (Cashmere) production while Barbari is not-selected for this trait. So, the mRNA expression profiling in the skin samples of both breeds would be an attractive and judicious approach for detecting putative genes involved in this valued trait. Here, we performed differential gene expression analysis on publicly available RNA-Seq data from both breeds. Out of 44,617,994 filtered reads of Pashmina and 55,995,999 of Barbari which are 76.48% and 73.69% mapped to the ARS1 reference transcriptome assembly respectively. A Pairwise comparison of both breeds resulted in 47,159 normalized expressed transcripts while 8,414 transcripts are differentially expressed above the significant threshold. Among these, 4,788 are upregulated in Pashmina while 3,626 transcripts are upregulated in Barbari. Fifty-nine transcripts harbor 57 genes including 32 LOC genes and 24 are annotated genes which were selected on the basis of TMM counts > 500.
    [Show full text]
  • The Correlation of Keratin Expression with In-Vitro Epithelial Cell Line Differentiation
    The correlation of keratin expression with in-vitro epithelial cell line differentiation Deeqo Aden Thesis submitted to the University of London for Degree of Master of Philosophy (MPhil) Supervisors: Professor Ian. C. Mackenzie Professor Farida Fortune Centre for Clinical and Diagnostic Oral Science Barts and The London School of Medicine and Dentistry Queen Mary, University of London 2009 Contents Content pages ……………………………………………………………………......2 Abstract………………………………………………………………………….........6 Acknowledgements and Declaration……………………………………………...…7 List of Figures…………………………………………………………………………8 List of Tables………………………………………………………………………...12 Abbreviations….………………………………………………………………..…...14 Chapter 1: Literature review 16 1.1 Structure and function of the Oral Mucosa……………..…………….…..............17 1.2 Maintenance of the oral cavity...……………………………………….................20 1.2.1 Environmental Factors which damage the Oral Mucosa………. ….…………..21 1.3 Structure and function of the Oral Mucosa ………………...….……….………...21 1.3.1 Skin Barrier Formation………………………………………………….……...22 1.4 Comparison of Oral Mucosa and Skin…………………………………….……...24 1.5 Developmental and Experimental Models used in Oral mucosa and Skin...……..28 1.6 Keratinocytes…………………………………………………….….....................29 1.6.1 Desmosomes…………………………………………….…...............................29 1.6.2 Hemidesmosomes……………………………………….…...............................30 1.6.3 Tight Junctions………………………….……………….…...............................32 1.6.4 Gap Junctions………………………….……………….….................................32
    [Show full text]
  • Appendix 2. Significantly Differentially Regulated Genes in Term Compared with Second Trimester Amniotic Fluid Supernatant
    Appendix 2. Significantly Differentially Regulated Genes in Term Compared With Second Trimester Amniotic Fluid Supernatant Fold Change in term vs second trimester Amniotic Affymetrix Duplicate Fluid Probe ID probes Symbol Entrez Gene Name 1019.9 217059_at D MUC7 mucin 7, secreted 424.5 211735_x_at D SFTPC surfactant protein C 416.2 206835_at STATH statherin 363.4 214387_x_at D SFTPC surfactant protein C 295.5 205982_x_at D SFTPC surfactant protein C 288.7 1553454_at RPTN repetin solute carrier family 34 (sodium 251.3 204124_at SLC34A2 phosphate), member 2 238.9 206786_at HTN3 histatin 3 161.5 220191_at GKN1 gastrokine 1 152.7 223678_s_at D SFTPA2 surfactant protein A2 130.9 207430_s_at D MSMB microseminoprotein, beta- 99.0 214199_at SFTPD surfactant protein D major histocompatibility complex, class II, 96.5 210982_s_at D HLA-DRA DR alpha 96.5 221133_s_at D CLDN18 claudin 18 94.4 238222_at GKN2 gastrokine 2 93.7 1557961_s_at D LOC100127983 uncharacterized LOC100127983 93.1 229584_at LRRK2 leucine-rich repeat kinase 2 HOXD cluster antisense RNA 1 (non- 88.6 242042_s_at D HOXD-AS1 protein coding) 86.0 205569_at LAMP3 lysosomal-associated membrane protein 3 85.4 232698_at BPIFB2 BPI fold containing family B, member 2 84.4 205979_at SCGB2A1 secretoglobin, family 2A, member 1 84.3 230469_at RTKN2 rhotekin 2 82.2 204130_at HSD11B2 hydroxysteroid (11-beta) dehydrogenase 2 81.9 222242_s_at KLK5 kallikrein-related peptidase 5 77.0 237281_at AKAP14 A kinase (PRKA) anchor protein 14 76.7 1553602_at MUCL1 mucin-like 1 76.3 216359_at D MUC7 mucin 7,
    [Show full text]
  • MALE Protein Name Accession Number Molecular Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean H Mean PDAC Mean T-Test PDAC Vs. H T-Test
    MALE t-test t-test Accession Molecular H PDAC PDAC vs. PDAC vs. Protein Name Number Weight CP1 CP2 H1 H2 PDAC1 PDAC2 CP Mean Mean Mean H CP PDAC/H PDAC/CP - 22 kDa protein IPI00219910 22 kDa 7 5 4 8 1 0 6 6 1 0.1126 0.0456 0.1 0.1 - Cold agglutinin FS-1 L-chain (Fragment) IPI00827773 12 kDa 32 39 34 26 53 57 36 30 55 0.0309 0.0388 1.8 1.5 - HRV Fab 027-VL (Fragment) IPI00827643 12 kDa 4 6 0 0 0 0 5 0 0 - 0.0574 - 0.0 - REV25-2 (Fragment) IPI00816794 15 kDa 8 12 5 7 8 9 10 6 8 0.2225 0.3844 1.3 0.8 A1BG Alpha-1B-glycoprotein precursor IPI00022895 54 kDa 115 109 106 112 111 100 112 109 105 0.6497 0.4138 1.0 0.9 A2M Alpha-2-macroglobulin precursor IPI00478003 163 kDa 62 63 86 72 14 18 63 79 16 0.0120 0.0019 0.2 0.3 ABCB1 Multidrug resistance protein 1 IPI00027481 141 kDa 41 46 23 26 52 64 43 25 58 0.0355 0.1660 2.4 1.3 ABHD14B Isoform 1 of Abhydrolase domain-containing proteinIPI00063827 14B 22 kDa 19 15 19 17 15 9 17 18 12 0.2502 0.3306 0.7 0.7 ABP1 Isoform 1 of Amiloride-sensitive amine oxidase [copper-containing]IPI00020982 precursor85 kDa 1 5 8 8 0 0 3 8 0 0.0001 0.2445 0.0 0.0 ACAN aggrecan isoform 2 precursor IPI00027377 250 kDa 38 30 17 28 34 24 34 22 29 0.4877 0.5109 1.3 0.8 ACE Isoform Somatic-1 of Angiotensin-converting enzyme, somaticIPI00437751 isoform precursor150 kDa 48 34 67 56 28 38 41 61 33 0.0600 0.4301 0.5 0.8 ACE2 Isoform 1 of Angiotensin-converting enzyme 2 precursorIPI00465187 92 kDa 11 16 20 30 4 5 13 25 5 0.0557 0.0847 0.2 0.4 ACO1 Cytoplasmic aconitate hydratase IPI00008485 98 kDa 2 2 0 0 0 0 2 0 0 - 0.0081 - 0.0
    [Show full text]
  • Transcriptome Profiling of the Lungs Reveals Molecular Clock Genes Expression Changes After Chronic Exposure to Ambient Air Particles
    Int. J. Environ. Res. Public Health 2017, 14, 0090; doi:10.3390/ijerph14010090 S1 of S6 Supplementary Materials: Transcriptome Profiling of the Lungs Reveals Molecular Clock Genes Expression Changes after Chronic Exposure to Ambient Air Particles Pengcheng Song, Zhigang Li, Xiaoqian Li, Lixin Yang, Lulu Zhang, Nannan Li, Chen Guo, Shuyu Lu and Yongjie Wei Table S1. The primers for real-time PCR. Gene Name Forward (5'—3') Reverse (5'—3') Per1 CAGCAGTGGAGTCTGGAGGA TAGGAGCTCTGAGAAGCGGG Per2 AGCCCTGCAGCATGGAAGTA ACGTCATGAGGAGCCAGGAA Per3 TGTGTTCAAGGGTCCACTGC GGTGCTGGCAACTTCTTTCG Bmal1 CCAAGAAAGTATGGACACAGACAAA GCATTCTTGATCCTTCCTTGGT Clock TTGCTCCACGGGAATCCTT GGAGGGAAAGTGCTCTGTTGTAG Cry1 CTGGCGTGGAAGTCATCGT CTGTCCGCCATTGAGTTCTATG Cry2 TGTCCCTTCCTGTGTGGAAGA GCTCCCAGCTTGGCTTGA REV-ERBα GGGCACAAGCAACATTACCA CACGTCCCCACACACCTTAC Dbp AAGGAGCGCAAGGCAACTCT AGATGTCAAGCCTGCGCGGT Gapdh CCCTTAAGAGGGATGCTGCC TACGGCCAAATCCGTTCACA Table S2. Overlap genes of 4 groups data of RNA-Seq. Adcy9 Cxcl14 Per1 A2m Arntl Cxcl2 Per2 Alas1 Ccl11 Cxcl6 Per3 Alox15 Ccl2 Gng10 Tnf Ddit4 Ccl20 Ifnk Tnfsf10 Efnb2 Ccl9 Il10 Hif3a Epas1 Cry1 Il1b Trim16 Fabp4 Ctf1 Il6 Prl8a2 Tef Cxcl1 Lifr Prl4a1 Table S3. DAVID bioinformatics for functional annotation. Term Count % p-Value Cytokine-cytokine receptor interaction 12 34.2857143 1.27E-10 Chemokine signaling pathway 10 28.5714286 8.32E-09 TNF signaling pathway 7 20 2.31E-06 Circadian rhythm 5 14.2857143 4.03E-06 Herpes simplex infection 8 22.8571429 1.05E-05 Rheumatoid arthritis 6 17.1428571 1.60E-05 Legionellosis 5 14.2857143 5.41E-05 Malaria 5 14.2857143 6.20E-05 Pertussis 5 14.2857143 1.43E-04 African trypanosomiasis 4 11.4285714 3.62E-04 Circadian entrainment 5 14.2857143 4.28E-04 Chagas disease (American 5 14.2857143 6.21E-04 trypanosomiasis) NOD-like receptor signaling pathway 4 11.4285714 0.001137577 Jak-STAT signaling pathway 5 14.2857143 0.001482411 Inflammatory bowel disease (IBD) 4 11.4285714 0.001752567 Int.
    [Show full text]
  • Supplementary Table 1
    Supplementary Table 1. 492 genes are unique to 0 h post-heat timepoint. The name, p-value, fold change, location and family of each gene are indicated. Genes were filtered for an absolute value log2 ration 1.5 and a significance value of p ≤ 0.05. Symbol p-value Log Gene Name Location Family Ratio ABCA13 1.87E-02 3.292 ATP-binding cassette, sub-family unknown transporter A (ABC1), member 13 ABCB1 1.93E-02 −1.819 ATP-binding cassette, sub-family Plasma transporter B (MDR/TAP), member 1 Membrane ABCC3 2.83E-02 2.016 ATP-binding cassette, sub-family Plasma transporter C (CFTR/MRP), member 3 Membrane ABHD6 7.79E-03 −2.717 abhydrolase domain containing 6 Cytoplasm enzyme ACAT1 4.10E-02 3.009 acetyl-CoA acetyltransferase 1 Cytoplasm enzyme ACBD4 2.66E-03 1.722 acyl-CoA binding domain unknown other containing 4 ACSL5 1.86E-02 −2.876 acyl-CoA synthetase long-chain Cytoplasm enzyme family member 5 ADAM23 3.33E-02 −3.008 ADAM metallopeptidase domain Plasma peptidase 23 Membrane ADAM29 5.58E-03 3.463 ADAM metallopeptidase domain Plasma peptidase 29 Membrane ADAMTS17 2.67E-04 3.051 ADAM metallopeptidase with Extracellular other thrombospondin type 1 motif, 17 Space ADCYAP1R1 1.20E-02 1.848 adenylate cyclase activating Plasma G-protein polypeptide 1 (pituitary) receptor Membrane coupled type I receptor ADH6 (includes 4.02E-02 −1.845 alcohol dehydrogenase 6 (class Cytoplasm enzyme EG:130) V) AHSA2 1.54E-04 −1.6 AHA1, activator of heat shock unknown other 90kDa protein ATPase homolog 2 (yeast) AK5 3.32E-02 1.658 adenylate kinase 5 Cytoplasm kinase AK7
    [Show full text]
  • PCDHGA9 Represses Epithelial-Mesenchymal Transition and Metastatic Potential in Gastric Cancer Cells by Reducing Β-Catenin Tran
    Weng et al. Cell Death and Disease (2020) 11:206 https://doi.org/10.1038/s41419-020-2398-z Cell Death & Disease ARTICLE Open Access PCDHGA9 represses epithelial-mesenchymal transition and metastatic potential in gastric cancer cells by reducing β-catenin transcriptional activity Junyong Weng 1,2, Shanbao Li3, Hao lin4,HaitaoMei1,YangLiu1,ChaoXiao1,5, Zhonglin Zhu1,6,WeiweiCai7, Xusheng Ding2,YushuaiMi8 and Yugang Wen1 Abstract Gastric cancer (GC) has a high mortality rate, and metastasis is the main reason for treatment failure. It is important to study the mechanism of tumour invasion and metastasis based on the regulation of key genes. In a previous study comparing the expression differences between GES-1 and SGC-7901 cells, PCDHGA9 was selected for further research. In vitro and in vivo experiments showed that PCDHGA9 inhibited invasion and metastasis. A cluster analysis suggested that PCDHGA9 inhibited epithelial-mesenchymal transition (EMT) through the Wnt/β-catenin and TGF-β pathways. Laser confocal techniques and western blotting revealed that PCDHGA9 inhibited the nuclear translocation of β-catenin, regulated T cell factor (TCF)/ /lymphoid enhancer factor (LEF) transcriptional activity, directly impacted the signal transmission of the TGF-β/Smad2/3 pathway, strengthened the adhesion complex, weakened the effects of TGF-β, and blocked the activation of the Wnt pathway. In addition, PCDHGA9 expression was regulated by methylation, which was closely related to poor clinical prognosis. The aim of this study was to elucidate the molecular mechanism by which PCDHGA9 inhibits EMT and metastasis in GC to provide a new theoretical basis for identifying 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; GC metastasis and a new target for improving the outcome of metastatic GC.
    [Show full text]
  • K2C1B Polyclonal Antibody
    K2C3 Polyclonal Antibody Catalog No : YN0251 Reactivity : Human,Rat,Mouse, Applications : WB,ELISA Gene Name : KRT3 Protein Name : Keratin, type II cytoskeletal 3 (65 kDa cytokeratin) (Cytokeratin-3) (CK-3) (Keratin-3) (K3) (Type-II keratin Kb3) Human Gene Id : 3850 Human Swiss Prot P12035 No : Immunogen : Synthesized peptide derived from human protein . at AA range: 230-310 Specificity : K2C3 Polyclonal Antibody detects endogenous levels of protein. Formulation : Liquid in PBS containing 50% glycerol, and 0.02% sodium azide. Source : Rabbit Dilution : WB 1:500-2000 ELISA 1:5000-20000 Purification : The antibody was affinity-purified from rabbit antiserum by affinity- chromatography using epitope-specific immunogen. Concentration : 1 mg/ml Storage Stability : -20°C/1 year Observed Band : 69 Background : keratin 3(KRT3) Homo sapiens The protein encoded by this gene is a member of the keratin gene family. The type II cytokeratins consist of basic or neutral proteins which are arranged in pairs of heterotypic keratin chains coexpressed during differentiation of simple and stratified epithelial tissues. This type II 1 / 2 cytokeratin is specifically expressed in the corneal epithelium with family member KRT12 and mutations in these genes have been associated with Meesmann's Corneal Dystrophy. The type II cytokeratins are clustered in a region of chromosome 12q12-q13. [provided by RefSeq, Jul 2008], Function : disease:Defects in KRT3 are a cause of Meesmann corneal dystrophy (MCD) [MIM:122100]. MCD is an autosomal dominant disease that causes fragility of the anterior corneal epithelium. Patients are usually asymptomatic until adulthood when rupture of the corneal microcysts may cause erosions, producing clinical symptoms such as photophobia, contact lens intolerance and intermittent diminution of visual acuity.
    [Show full text]
  • Damage of Hair Follicle Stem Cells and Alteration of Keratin Expression in External Radiation-Induced Acute Alopecia
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 30: 579-584, 2012 Damage of hair follicle stem cells and alteration of keratin expression in external radiation-induced acute alopecia NAOKI NANASHIMA, KOICHI ITO, TAKASHI ISHIKAWA, MANABU NAKANO and TOSHIYA NAKAMURA Department of Biomedical Sciences, Division of Medical Life Sciences, Hirosaki University Graduate School of Health Sciences, Hirosaki, Japan Received April 4, 2012; Accepted May 28, 2012 DOI: 10.3892/ijmm.2012.1018 Abstract. Alopecia is known as a symptom of acute radia- disturbances and blood and bone marrow disorders are known tion, yet little is known concerning the mechanism of this to occur within several hours to several weeks after 1-6 Gy of phenomenon and the alteration of hair protein profiles. To radiation exposure (4,6). examine this, 6-week-old male C57/BL6 mice were exposed Hair loss is also an effect of ARS, but little is known to 6 Gy of X-ray irradiation, which caused acute alopecia. about the mechanism underlying radiation-induced hair loss. Their hair and skin were collected, and hair proteins were In humans, hair loss is caused by radiation of more than analyzed with liquid chromatography/electrospray-ionization 3 Gy, and almost complete hair loss occurs within weeks of mass spectrometry and immunohistochemistry. No change exposure to 6 Gy (4,6). Since blood stem cells are sensitive to was observed in the composition of major hair keratins, such radiation (7), hair loss is thought to be caused by irradiation- as Krt81, Krt83 and Krt86. However, cytokeratin Krt15 and induced stem cell damage, yet no studies have investigated CD34, which are known as hair follicle stem cell markers, this hypothesis.
    [Show full text]
  • Types I and II Keratin Intermediate Filaments
    Downloaded from http://cshperspectives.cshlp.org/ on October 10, 2021 - Published by Cold Spring Harbor Laboratory Press Types I and II Keratin Intermediate Filaments Justin T. Jacob,1 Pierre A. Coulombe,1,2 Raymond Kwan,3 and M. Bishr Omary3,4 1Department of Biochemistry and Molecular Biology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland 21205 2Departments of Biological Chemistry, Dermatology, and Oncology, School of Medicine, and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland 21205 3Departments of Molecular & Integrative Physiologyand Medicine, Universityof Michigan, Ann Arbor, Michigan 48109 4VA Ann Arbor Health Care System, Ann Arbor, Michigan 48105 Correspondence: [email protected] SUMMARY Keratins—types I and II—are the intermediate-filament-forming proteins expressed in epithe- lial cells. They are encoded by 54 evolutionarily conserved genes (28 type I, 26 type II) and regulated in a pairwise and tissue type–, differentiation-, and context-dependent manner. Here, we review how keratins serve multiple homeostatic and stress-triggered mechanical and nonmechanical functions, including maintenance of cellular integrity, regulation of cell growth and migration, and protection from apoptosis. These functions are tightly regulated by posttranslational modifications and keratin-associated proteins. Genetically determined alterations in keratin-coding sequences underlie highly penetrant and rare disorders whose pathophysiology reflects cell fragility or altered
    [Show full text]
  • It Was Hypothesized That Hybrid Synthetic/Adenoviral Nanoparticles
    Electronic Supplementary Material (ESI) for Nanoscale. This journal is © The Royal Society of Chemistry 2020 SUPPORTING INFORMATION Lana Papafilippou,a Andrew Claxton,b Paul Dark,b,c Kostas Kostarelos*a,d and Marilena Hadjidemetriou*a aNanomedicine Lab, Faculty of Biology, Medicine & Health, AV Hill Building, The University of Manchester, Manchester, M13 9PT, UK bCentre for Acute Care Trauma, Manchester Academic Health Science Centre, Health Innovation Manchester, Division of Critical Care, Salford Royal NHS Foundation Trust, Greater Manchester, UK cDivision of Infection, Immunity and Respiratory Medicine, Faculty of Biology, Medicine & Health, AV Hill Building, The University of Manchester, Manchester, M13 9PT, UK. d Catalan Institute of Nanoscience and Nanotechnology (ICN2), Campus UAB, Bellaterra, 08193 Barcelona, Spain. _______________________________________ * Correspondence should be addressed to: [email protected],uk; [email protected] 1 Supporting Figure 1 Figure S1: Physicochemical characterization of corona-coated Amphotericin B-intercalated liposomes (AmBisome®). Mean hydrodynamic diameter (nm) and ζ-potential (mV) distributions are depicted for corona-coated liposomal formulation AmBisome® recovered post-incubation with human plasma from 12 healthy volunteers, 7 SIRS patients and 12 sepsis patients. 2 Supporting Figure 2 Figure S2: Proteomic analysis of corona profiles. (A) Heatmap of normalized abundance values of all corona proteins identified in healthy controls, SIRS patients and sepsis patients, as identified by LC-MS/MS (Progenesis QI). Protein columns are sorted according to the abundance values (from highest to lowest) of the first sample. The list of proteins shown in the heatmap, their respective accession numbers and their mean normalized abundance values are shown in Table S5; (B) Volcano plot represents the potential protein biomarkers differentially abundant between healthy donors and sepsis patients (n=135) identified in corona samples.
    [Show full text]